A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

(2010) Joseph N Jarvis et al.   BMC INFECTIOUS DISEASES

High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out

(2009) Joseph N Jarvis et al.   AIDS

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi

(2009) Jesse C. Nussbaum et al.   CLINICAL INFECTIOUS DISEASES

Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda

(2008) Nicky Longley et al.   CLINICAL INFECTIOUS DISEASES

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

(2008) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis

(2008) Eric Milefchik et al.   MEDICAL MYCOLOGY